KERX

Keryx Biopharmaceuticals, Inc. News Headlines

$17.81
*  
0.37
2.04%
Get KERX Alerts
*Delayed - data as of Aug. 28, 2014  -  Find a broker to begin trading KERX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

AcelRx Pharmaceuticals To Submit NDA By End Of September, May Be Acquired Soon
9/20/2013 7:55:00 AM - Seeking Alpha

Keryx Biopharmaceuticals (KERX) Enters Overbought Territory - Tale of the Tape
9/18/2013 5:57:32 AM - Zacks.com

My Magic Screen Came Up With These 2 Likely Biotech Winners
9/12/2013 8:38:00 AM - Seeking Alpha

Rockwell Medical Inc: SFP's Market Potential
9/8/2013 2:44:00 AM - Seeking Alpha

Don't Miss These 3 Healthcare Sweet Spots
8/24/2013 3:32:00 AM - Seeking Alpha

Upcoming Catalyst Could Spark Another Run For Insmed
8/14/2013 11:22:00 AM - Seeking Alpha

Keryx Biopharmaceuticals Presents An Attractive Investment Opportunity
7/24/2013 10:28:00 AM - Seeking Alpha

Significant Near-Term Catalyst Should Further Rally Keryx Pharmaceuticals
7/24/2013 8:00:00 AM - Seeking Alpha

Keryx Biopharmaceuticals' Zerenex Likely To Receive FDA Approval
7/22/2013 3:07:00 PM - Seeking Alpha

3 Biotechs With Strong Momentum - Can They Keep It Up?
6/19/2013 1:40:00 PM - Seeking Alpha

Mid-Day Market Update: La-Z-Boy Drops On Q4 Results, Nektar Gains
6/19/2013 12:32:56 PM - Benzinga

Mid-Morning Market Update: Markets Edge Lower, FedEx Posts Upbeat Profit
6/19/2013 10:32:42 AM - Benzinga

Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big Pharma With Ground-Breaking Cancer Therapy
6/5/2013 5:53:00 AM - Seeking Alpha

Solid Showing At WCN Conference For Keryx: Catalysts Still To Come
6/4/2013 2:22:00 PM - Seeking Alpha

Clovis Among Top Small-Cap Biotech Picks By Legendary Fund Managers In Q1/2013
6/4/2013 5:26:00 AM - Seeking Alpha

Keryx: Attractive In Front Of Catalyst-Rich Second Half
5/30/2013 10:47:00 AM - Seeking Alpha

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
5/28/2013 7:57:00 AM - Seeking Alpha

A Review Of Upcoming Catalysts For Kidney Disease Biotech Players In 2013
5/24/2013 8:17:00 AM - Seeking Alpha

Weekly Stock Watch - Week Of May 13, 2013
5/11/2013 11:06:00 PM - Seeking Alpha

Recent Noteworthy Institutional 5% Ownership Filings In Healthcare Sector
5/9/2013 3:46:00 AM - Seeking Alpha

Keryx: A Small Biotech With Many Catalysts
5/8/2013 9:30:00 AM - Seeking Alpha

Whisper Number Impact: Earnings Preview For Keryx Biopharmaceuticals
5/7/2013 3:39:00 PM - Seeking Alpha

NewLink Genetics: Looking To Join The Industry's Largest Movers
4/29/2013 5:51:00 AM - Seeking Alpha

Keryx, Zerenex, And IP Protection: A PropThink Conference Call
4/22/2013 3:02:00 PM - Seeking Alpha

Keryx BioPharmaceuticals: A Favorite Of Mine In The Pharmacology World
4/22/2013 4:59:00 AM - Seeking Alpha